We are live on ! Find out more
NCM

NovaQuest Capital Management Portfolio holdings

AUM $54.3M
1-Year Est. Return 163.39%
This Fund
S&P 500
This Quarter Est. Return
-31.38%
1 Year Est. Return
+163.39%
3 Year Est. Return
+45.13%
5 Year Est. Return
10 Year Est. Return
AUM
$88.4M
AUM Growth
+$18.1M
Cap. Flow
+$45.1M
Cap. Flow %
50.99%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
MYOV
Myovant Sciences Ltd.
MYOV
+$45.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOV
1
DELISTED
Myovant Sciences Ltd.
MYOV
$57M 64.51%
3,474,645
+2,286,284
+192% +$45.1M
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$31.4M 35.49%
1,558,426

Similar funds

NovaQuest Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, NovaQuest Capital Management held 2 positions worth $88.4M, up 26% from $70.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

NovaQuest Capital Management deployed $45.1M of net new capital in Q4 2018, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • NovaQuest Capital Management added most to Myovant Sciences Ltd. in Q4 2018, an estimated $45.1M increase.
  • NovaQuest Capital Management's ten largest holdings make up 100% of its $88.4M portfolio in Q4 2018.
  • NovaQuest Capital Management opened 0 new positions and closed 0 in Q4 2018.
  • NovaQuest Capital Management's portfolio value rose 26% quarter-over-quarter to $88.4M.

Based on NovaQuest Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.